Kent Bernard brings a unique perspective to antitrust, healthcare and the interplay between U.S. and other competition law regimes, topics on which he has practiced, spoken and written.
After starting his career in a law firm, Mr. Bernard moved in house in 1978. From 1980 until 2008 he held a series of increasingly responsible in-house legal positions at Pfizer Inc., retiring as Vice President & Assistant General Counsel and Deputy Managing Partner of the Pfizer Legal Division.
Mr. Bernard's responsibilities ranged widely, from helping to acquire and then being the General Counsel of Schneider Medintag, a maker of sophisticated interventional cardiology devices that grew to become the most profitable company within the Pfizer Medical Devices group, to working on matters across the parent company spectrum including: Planning, structuring and implementing worldwide antitrust and competition law clearances for some of the largest acquisitions in the pharmaceutical industry; Establishing direct relations with competition authorities in the U.S., the EU, and elsewhere; setting up a worldwide network of law firms; providing and coordinating worldwide legal support for marketing and other programs.
